AEDs: Translating Recent Data into Clinical Applications : Epilepsy.com/Professionals

WHO IS EPILEPSY.COM/PROFESSIONALS

DONATE

AEDs: Translating Recent Data into Clinical Applications

Jointly sponsored by the NYU
Post-Graduate Medical School
and Imprint Science

Release date:
Expiration date:

July 21, 2006
July 21, 2007

Program Description

Exciting new clinical findings regarding the use of AEDs offer additional guidance to the clinician treating neurologic and psychiatric disorders. For example, updated information is available regarding the impact of AEDs on a woman’s health, particularly across the reproductive stages, as well as on issues that might lead to drug resistance.

This symposium offers participants insight into these issues as well as providing a better understanding of the clinical manifestations of seizures if left untreated. It Identifies any overt or hidden comorbid psychiatric disorders, and identifies the effect of AEDs on sleep patterns. In addition, current neuroimaging technologies to better evaluate patients with neurologic disorders are reviewed. It is hoped that the clinicians will utilize these data in clinical practice to improve the lives of their patients.

For further information about this Internet CME activity, contact the NYU Post-Graduate Medical School at 212-263-5292.
For further information about NYU's privacy and confidentiality policy, click here.

Hardware and Software Requirements

PC: Pentium II or better with sound support, 16 bits color resolution, and 1024x768 pixels minimum screen resolution. Windows 95 or better, running Internet Explorer 5+ or Netscape 7.0+, Javascript enabled, and Flash 7.0 installed.

Mac: G3 or better with sound support, 16 bits color resolution, and 1024x768 pixels minimum screen resolution. Os X, running Safari 1.0 or Firefox 1.0, Javascript enabled, and Flash 7.0 installed.

Needs Statement

Evaluative and technological tools for diagnosing and treating epilepsy are developing rapidly. However, when selecting AED therapies, physicians still do not recognize the different impacts that individual AEDs may have within subsets of the population of patients with epilepsy. Thus, women with epilepsy who are of childbearing age are not always counseled concerning the teratogenic potential of certain AEDs, and patients who exhibit an emerging drug-resistance profile may not be efficiently switched to another AED therapy. A more in-depth understanding among clinicians of the variations among AEDs could also benefit the design of AED therapies for patients with comorbid psychiatric problems or therapy-related sleeping disorders. Finally, clinicians who diagnose and treat epilepsy are not always aware of the range of benefits available from the latest in neuroimaging technologies.

Target Audience

This activity has been designated for neurologists, epileptologists, psychiatrists, OB/GYNs, internists, and PCPs.

Educational Objectives

Utilize current data regarding the potential teratogenicity of AEDs in women of childbearing age with epilepsy in order to educate those patients so they will be able to reach informed decisions regarding their current and future drug treatment during preconception years.

Identify and evaluate a drug-resistance profile in patients who continue to experience seizures while on certain AED therapies, and to offer alternate therapeutic options early in their treatment.

Recognize the effects of certain AEDs on different stages of sleep and overall sleep patterns when selecting an AED appropriate to each patient with epilepsy in order to minimize sleep disturbances.

Define and interpret the physiologic, structural, cognitive, and behavioral abnormalities that may offer evidence of seizures in patients with epilepsy so as to minimize potential damage to the brain.

Distinguish and treat appropriately the comorbidities of psychiatric and neurologic disorders that often burden patients with epilepsy in order to improve their quality of life.

Incorporate the contributions of neuroimaging information to broaden and strengthen the diagnosis of patients with epilepsy in order to minimize potential damage to the brain.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of NYU Post-Graduate Medical School and Imprint Science. NYU Post-Graduate Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The NYU Post-Graduate Medical School designates this educational activity for a maximum of 4.25 AMA PRA Category 1 credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

Estimated Time for Completion:	4.25 hours
Release Date:	July 20, 2006
Expiration Date:	July 20, 2007

Faculty List

Orrin Devinsky, MD Professor of Neurology, Neurosurgery and Psychiatry NYU School of Medicine New York, NY	Ruben I. Kuzniecky, MD Professor of Neurology NYU School of Medicine New York, NY
Blanca R. Vazquez, MD Clinical Assistant Professor of Neurology NYU School of Medicine New York, NY	Siddhartha S. Nadkarni, MD Assistant Professor of Medicine NYU School of Medicine New York, NY
Jaideep Kapur, MD, PhD Assistant Professor of Neurology University of Virginia School of Medicine Charlottesville, VA	Alcibiades Rodriguez, MD Assistant Professor of Neurology NYU School of Medicine New York, NY

Disclosure Statement

The NYU Post-Graduate Medical School adheres to ACCME Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified Conflicts of Interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty is listed below.

Orrin Devinsky, MD Course Director	This presentation *will not* include discussion of the unlabeled or unapproved use of a drug, medical device or procedure.
GlaxoSmithKline, UCB	Speakers’ Bureau
Blanca Vazquez, MD Course Director	This presentation *will not* include discussion of the unlabeled or unapproved use of a drug, medical device or procedure.
Abbott Labs, Eisai Pharma, GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer, UCB	Consulting Fees
Abbott Labs, Eisai Pharma, GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer, UCB	Fees For Non-CME Services
Abbott Labs, Eisai Pharma, GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer, UCB	Contracted Research
Jaideep Kapur, MD, PhD Presenter	This presentation *will not* include discussion of the unlabeled or unapproved use of a drug, medical device or procedure.
	No financial relationships to disclose
Ruben Kuzniecky, MD Presenter	This presentation *will not* include discussion of the unlabeled or unapproved use of a drug, medical device or procedure.
	No financial relationships to disclose
Siddhartha Nadkarni, MD Presenter	This presentation *will not* include discussion of the unlabeled or unapproved use of a drug, medical device or procedure.
	No financial relationships to disclose
Alcibiades Rodriguez, MD Presenter	This presentation *will not* include discussion of the unlabeled or unapproved use of a drug, medical device or procedure.
GlaxoSmithKline	Fees For Non-CME Services
Jacki Gordon, PhD Editor	No financial relationships to disclose
The independent reviewer of this activity has indicated that she has no financial relationships to disclose.
Supported by an educational grant from GlaxoSmithKline.

Full Program

User instructions: The hyperlinks listed below will send you to our partner site where you may view each of the individual presentations, including viewing the speaker, following the slides, and reading the transcript. You will notice a drop-down menu in the upper left corner of the browser window, which will allow you to customize your viewing preferences and provide an option to download copies of each session's supporting transcript and PowerPoint presentation. Use this menu if you do not immediately see the video, slides, or transcript. The double-sided arrow permits a toggle between two windows so that either the video or the slides is prominent.

	Antiepileptic Drugs and Women: Preconception Pathways and Pregnancy Registries Blanca Vazquez, MD

	Mechanisms of Drug Resistance: What Have We Learned? Jaideep Kaipur, MD, PhD

	Q & A and Panel Discussion

	Effects of Antiepileptic Drugs on Sleep Alcibiades Rodriguez, MD

	Progression of Epilepsy: A Review and Case Study Orrin Devinsky, MD

	Q & A and Panel Discussion

	AEDs and Comorbid Psychiatric Disorders Siddhartha Nadkarni, MD (no video of speaker)

	Advances in Neuroimaging: Epilepsy, Alzheimer's Disease, and Other Neurologic Disorders Ruben Kuzniecky, MD

Method of Participation

Physicians: To receive up to 4.25 AMA Category 1 credits, you must view the activity, and download the post-test and evaluation form. Answer each test question (minimum passing grade of 70%), and complete the evaluation form.
Return the post-test, evaluation, and attestation by mail or fax no later than July 17, 2007 to:

NYU Post-Graduate Medical School
550 First Avenue, SLH 4-20-O
New York, NY 10016
Fax: 212-263-5293

Copyrights

Unless otherwise noted, all documents accessed from this page are viewed as a precious resource of NYU and are Copyright, New York University, all rights reserved. Use of any data or other materials accessed from this site without the permission of the authors and the University may result in action being taken against offenders.